Molnupiravir
Uses
Get news alerts from PBS NewsHour Turn on desktop notifications? Yes Not now
Warnings
Department of Health and Ageing
Since July 2022, the Australian Government has approved extra funding for 102 new and amended listings on the PBS
To refine your search select one of the options below
Molnupiravir PBS eligibility criteria
PBS Schedule search for "molnupiravir" Did you mean? Drug Name [ Dolutegravir, Molnupiravir] Refine search
Menu
Molnupiravir dosing The recommended dose of molnupiravir is: 800mg (4 x 200mg capsules) taken orally every 12 hours for 5 days
Molnupiravir dosing requirements for treatment of COVID-19 The recommended dose of molnupiravir is: 800 mg (4 x 200mg capsules) taken orally every 12 hours for 5 days
Therapeutic Group
Oral antivirals have been an important addition to efforts to minimise adverse COVID-19 outcomes in individuals at high risk
A COVID-19 diagnosis can be confirmed by either a
Molnupiravir (Lagevrio®) has been provisionally approved by the Therapeutic Goods Administration for use in Australia for the treatment of adults with COVID-19 who do not require initiation of oxygen due to As per the PBS listing, adults (18 years and over) are eligible for treatment with molnupiravir if the patient: Introduction